Selection of phage-displayed human antibody fragments on Dengue virus particles captured by a monoclonal antibody: Application to the four serotypes

2008 ◽  
Vol 147 (2) ◽  
pp. 235-243 ◽  
Author(s):  
Sheila Cabezas ◽  
Gertrudis Rojas ◽  
Alequis Pavon ◽  
Mayling Alvarez ◽  
Maritza Pupo ◽  
...  
2010 ◽  
Vol 4 (11) ◽  
pp. e881 ◽  
Author(s):  
Nicole J. Moreland ◽  
Moon Y. F. Tay ◽  
Elfin Lim ◽  
Prasad N. Paradkar ◽  
Danny N. P. Doan ◽  
...  

2012 ◽  
Vol 87 (3) ◽  
pp. 1312-1321 ◽  
Author(s):  
Roberto Mateo ◽  
Claude M. Nagamine ◽  
Jeannie Spagnolo ◽  
Ernesto Méndez ◽  
Michael Rahe ◽  
...  

ABSTRACTAutophagy is an important component of the innate immune response, directly destroying many intracellular pathogens. However, some pathogens, including several RNA viruses, subvert the autophagy pathway, or components of the pathway, to facilitate their replication. In the present study, the effect of inhibiting autophagy on the growth of dengue virus was tested using a novel inhibitor, spautin-1 (specific andpotentautophagyinhibitor 1). Inhibition of autophagy by spautin-1 generated heat-sensitive, noninfectious dengue virus particles, revealing a large effect of components of the autophagy pathway on viral maturation. A smaller effect on viral RNA accumulation was also observed. Conversely, stimulation of autophagy resulted in increased viral titers and pathogenicity in the mouse. We conclude that the presence of functional autophagy components facilitates viral RNA replication and, more importantly, is required for infectious dengue virus production. Pharmacological inhibition of host processes is an attractive antiviral strategy to avoid selection of treatment-resistant variants, and inhibitors of autophagy may prove to be valuable therapeutics against dengue virus infection and pathogenesis.


2016 ◽  
Vol 5 (2) ◽  
pp. 120-127 ◽  
Author(s):  
Frank Camacho ◽  
María E. Sarmiento ◽  
Fatima Reyes ◽  
Louise Kim ◽  
Jim Huggett ◽  
...  

2021 ◽  
pp. 235-244
Author(s):  
Vivian Bonezi ◽  
Allan Henrique Depieri Cataneo ◽  
Pryscilla Fanini Wowk ◽  
Eduardo L. V. Silveira

2008 ◽  
Vol 73A (11) ◽  
pp. 1093-1099 ◽  
Author(s):  
Ralph Willemsen ◽  
Patrick Chames ◽  
Erik Schooten ◽  
Jan Willem Gratama ◽  
Reno Debets

Author(s):  
Yu-jia Jin ◽  
Diao Yu ◽  
Xiao-long Tian ◽  
Hui-xian Li ◽  
Xiao-chao Zhou ◽  
...  

AbstractPhage display technology allows for rapid selection of antibodies from the large repertoire of human antibody fragments displayed on phages. However, antibody fragments should be converted to IgG for biological characterizations and affinity of antibodies obtained from phage display library is frequently not sufficient for efficient use in clinical settings. Here, we describe a new approach that combines phage and mammalian cell display, enabling simultaneous affinity screening of full-length IgG antibodies. Using this strategy, we successfully obtained a novel germline-like anti-TIM-3 monoclonal antibody named m101, which was revealed to be a potent anti-TIM-3 therapeutic monoclonal antibody via in vitro and in vivo experiments, indicating its effectiveness and power. Thus, this platform can help develop new monoclonal antibody therapeutics with high affinity and low immunogenicity.


Sign in / Sign up

Export Citation Format

Share Document